IMMUNOLOGY QUALITY ASSESSMENT PROGRAM

免疫学质量评估计划

• 批准号: 9528361
• 负责人: Thomas Denny
• 金额: $ 151.52万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-30 至 2018-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9528361
• 关键词: CD8-Positive T-Lymphocytes; CD8B1 gene; Clinical Trials Network; Data; Diagnosis; Disease; Ensure; Freezing; Future; Immunologic Tests; Immunology; Laboratories; Laboratory Procedures; Libraries; Lymphocyte Count; Measures; Monitor; National Institute of Allergy and Infectious Disease; Online Systems; Performance; Peripheral Blood Mononuclear Cell; Procedures; Records; Reporting; Resolution; Resources; Site; Specific qualifier value; System; Testing; Training; base; computerized; cost; data management; instrument; new technology; novel; programs; repository; technology validation; CD8-Positive T-Lymphocytes; CD8B1 gene; Clinical Trials Network; Data; Diagnosis; Disease; Ensure; Freezing; Future; Immunologic Tests; Immunology; Laboratories; Laboratory Procedures; Libraries; Lymphocyte Count; Measures; Monitor; National Institute of Allergy and Infectious Disease; Online Systems; Performance; Peripheral Blood Mononuclear Cell; Procedures; Records; Reporting; Resolution; Resources; Site; Specific qualifier value; System; Testing; Training; base; computerized; cost; data management; instrument; new technology; novel; programs; repository; technology validation

The purpose of the Immunology Quality Assessment Program (IQA) is to continue and provide a resource to (1) evaluate the abilities of U.S. and non-U.S. laboratories to accurately and reliably perform study-specified immunological tests (with focus on CD4 and CD8 T cell lymphocyte counts and percentages) and viable PBMC freezing, (2) advise and train when deficiencies are identified, (3) evaluate immunology-based novel technologies (with focus on novel, simple tests for diagnosis and disease monitoring) for implementation in multi-site NIAID trials, and (4) maintain a computerized data management system and document library that include lab performance data and guidance documents. IQA will continue to support laboratories that are part of current and future NIAID-sponsored clinical trial networks

免疫学质量评估计划（IQA）的目的是继续并提供资源以（1）评估美国和非美国实验室的能力准确且可靠地执行研究指定的免疫学测试（重点介绍CD4和CD8 T细胞淋巴细胞和百分比和有可能的PBMC时，（3）识别和训练（2）提问，（2）提问，（2）基于免疫学的新技术（侧重于新颖的，用于诊断和疾病监测的简单测试），用于在多站点NIAID试验中实施，（4）维护计算机数据管理系统和文档库，其中包括实验室绩效数据和指导文档。 IQA将继续支持是当前和未来NIAID赞助的临床试验网络的一部分的实验室